The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alectinib in pediatric patients with solid or CNS tumors harboring ALK-fusions: Emerging pharmacokinetic data from the iMATRIX alectinib phase I/II open-label, multi-center study.
 
Francois Doz
Consulting or Advisory Role - Ipsen (Inst); Novartis (Inst); SERVIER (Inst)
Research Funding - ONXEO (Inst); SYNTH-INNOVE (Inst)
 
Michela Casanova
Consulting or Advisory Role - AstraZeneca; Bayer; Roche/Genentech; Servier
 
Kyung-Nam Koh
No Relationships to Disclose
 
Karsten Nysom
Consulting or Advisory Role - Bayer; Lilly
 
Adela Canete
No Relationships to Disclose
 
Hyoung Jin Kang
Consulting or Advisory Role - GPCR Therapeutics; Novartis; Recordati; Takeda
 
Matthias A. Karajannis
Consulting or Advisory Role - Alexion Pharmaceuticals; Cardinal Health; CereXis; Medscape; Physicans' Education Resource; QED Therapeautics; Recursion
 
Darren R. Hargrave
Honoraria - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bayer
Consulting or Advisory Role - AstraZeneca; Bayer; Biodexa; Boehringer Ingelheim; Novartis; Roche/Genentech
Speakers' Bureau - Alexion Pharmaceuticals
Research Funding - AstraZeneca
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; Boehringer Ingelheim; Novartis; Roche/Genentech
Other Relationship - Abbvie; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Day One Therapeutics; Epizyme; Novartis
 
Nadège Corradini
No Relationships to Disclose
 
Yeming Wu
No Relationships to Disclose
 
Huanmin Wang
No Relationships to Disclose
 
Thorsten Ruf
Employment - F- Hoffmann-La Roche Ltd/Genentech, Inc.
Stock and Other Ownership Interests - Roche
 
Gabriele Manzella
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Tao Xu
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Yachun Tai
Employment - Roche/Genentech
 
Nastya Kassir
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Dhruvitkumar S. Sutaria
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Francis Mussai
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Clare E. Devlin
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche
 
Amar J. Gajjar
Consulting or Advisory Role - Day One Therapeutics; Gennao Bio; QED Therapeutics; Roche/Genentech
Research Funding - Genentech (Inst); Kazia Therapeutics (Inst)